Teladoc Health Reports Second-Quarter 2021 Results, Raises Full-Year Revenue Guidance

NEXT STORY
AzurRx BioPharma Announces Closing of $5.75 Million Bought Deal Offering and Exercise in Full of Underwriter’s Option to Purchase Additional Shares
PREV STORY
NexImmune to Announce Second Quarter 2021 Financial Results and Provide Corporate Update on August 9, 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CorMedix Receives Encouraging FDA Feedback on Neutrolin® LOCK-IT-100 Data

author_avatar
NASDAQ Market News

Specialty Pharmaceuticals Market Research Report by Type, by Product, by Distribution Channel, by Region – Global Forecast to 2026 – Cumulative Impact of COVID-19

author_avatar
NASDAQ Market News

BeyondSpring Announces Positive Topline Interim Results from PROTECTIVE-2 (Study 106) Phase 3 Trial Evaluating Superiority of Plinabulin in Combination with Neulasta for Chemotherapy-Induced Neutropenia Prevention

author_avatar
NASDAQ Market News